Oruka Therapeutics (ORKA) Return on Equity [ROE] (2011 - 2024)
Oruka Therapeutics' Return on Equity [ROE] was -40.07% in Q1 2024, down 20.61 percentage points from -19.46% a year earlier and down 25.83 percentage points from the prior quarter.
Powered by 
Analysis
Oruka Therapeutics (ORKA) Return on Equity [ROE] (2011 - 2024) Analysis & Trends
For FY2023, Return on Equity [ROE] at Oruka Therapeutics came in at -13.57%, up 7.83 percentage points from FY2022.
- Return on Equity [ROE] shows a five-year change of +83.73 percentage points (FY2018 to FY2023).
- In earlier years, Return on Equity [ROE] was -21.40% in FY2022 (+18.21 pp), -39.61% in FY2021 (-3.63 pp), -35.98% in FY2020 (+44.39 pp) and -80.37% in FY2019 (+16.93 pp).
- The Q1 2024 figure marks the lowest quarterly Return on Equity [ROE] since Q2 2020.
- Compared with a year earlier, Return on Equity [ROE] was higher in five of the last eight quarters, with an average year-over-year change of +5.77 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2019 (a gain of 66.15 percentage points); the worst was Q1 2024 (a drop of 20.61 percentage points).
- Per Business Quant data, ORKA's Return on Equity [ROE] in the three quarters before Q1 2024 was -14.24% (Q4 2023), -14.05% (Q3 2023) and -15.87% (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Oruka Therapeutics | 5.31 Bn | 3.37 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -40.07% |
| Dec 31, 2023 | -14.24% |
| Sep 30, 2023 | -14.05% |
| Jun 30, 2023 | -15.87% |
| Mar 31, 2023 | -19.46% |
| Dec 31, 2022 | -23.51% |
| Sep 30, 2022 | -32.90% |
| Jun 30, 2022 | -36.18% |
| Mar 31, 2022 | -37.36% |
| Dec 31, 2021 | -35.90% |
| Sep 30, 2021 | -31.87% |
| Jun 30, 2021 | -25.25% |
| Mar 31, 2021 | -22.27% |
| Dec 31, 2020 | -20.08% |
| Sep 30, 2020 | -19.22% |
| Jun 30, 2020 | -60.25% |
| Mar 31, 2020 | -73.84% |
| Dec 31, 2019 | -66.82% |
| Sep 30, 2019 | -63.88% |
| Jun 30, 2019 | -74.90% |
API Access
Oruka Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ORKA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ORKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ORKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();